Firebrick Pharma Limited (AU:FRE) has released an update.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Firebrick Pharma Limited has announced the proposed issuance of 1.5 million options expiring in December 2027, priced at $0.09 each. This strategic move could attract investor interest and potentially enhance liquidity in the market. Investors keen on opportunities in the pharmaceutical sector may find this development noteworthy.
For further insights into AU:FRE stock, check out TipRanks’ Stock Analysis page.